Overview of Cost-effectiveness Analysis.
Publication
, Journal Article
Sanders, GD; Maciejewski, ML; Basu, A
Published in: JAMA
April 9, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 9, 2019
Volume
321
Issue
14
Start / End Page
1400 / 1401
Location
United States
Related Subject Headings
- Quality-Adjusted Life Years
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanders, G. D., Maciejewski, M. L., & Basu, A. (2019). Overview of Cost-effectiveness Analysis. JAMA, 321(14), 1400–1401. https://doi.org/10.1001/jama.2019.1265
Sanders, Gillian D., Matthew L. Maciejewski, and Anirban Basu. “Overview of Cost-effectiveness Analysis.” JAMA 321, no. 14 (April 9, 2019): 1400–1401. https://doi.org/10.1001/jama.2019.1265.
Sanders GD, Maciejewski ML, Basu A. Overview of Cost-effectiveness Analysis. JAMA. 2019 Apr 9;321(14):1400–1.
Sanders, Gillian D., et al. “Overview of Cost-effectiveness Analysis.” JAMA, vol. 321, no. 14, Apr. 2019, pp. 1400–01. Pubmed, doi:10.1001/jama.2019.1265.
Sanders GD, Maciejewski ML, Basu A. Overview of Cost-effectiveness Analysis. JAMA. 2019 Apr 9;321(14):1400–1401.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 9, 2019
Volume
321
Issue
14
Start / End Page
1400 / 1401
Location
United States
Related Subject Headings
- Quality-Adjusted Life Years
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences